LAMTOR3 and breast carcinoma: Taking into consideration the above report and recent findings identifying the LAMTOR complex as a convergence point for both the ERK and mTORC1 pathways, we aimed to investigate the potential role of mutations in LAMTOR3 and LAMTOR2 in the aetiology of breast cancer.